Impact of COVID-19 on the Pharma Industry and
associated shifts in their
outsourcing requirements

An Industry Survey, with additional analysis by Kevin Reid, Global VP Marketing and
Laura Montgomery, Senior Director, Marketing & Insights

Home /

Access the full document to find out more about:

  1. Exactly how R&D activity and clinical trials have been disrupted as a result of the pandemic.
  2. How the impact of COVID-19 has changed pharma, biotech & CROs needs now and post-COVID.
  3. How outsourced pharmaceutical providers can adapt, pivot and be effective during and post-pandemic.
Access the survey instantly here
This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies